Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 6505814, 7 pages
https://doi.org/10.1155/2017/6505814
Research Article

Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity

Diabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, Greece

Correspondence should be addressed to Maria E. Barmpari; moc.oohay@airam_irabrab

Received 21 June 2017; Revised 27 September 2017; Accepted 8 October 2017; Published 30 October 2017

Academic Editor: Εleni Bekiari

Copyright © 2017 Maria E. Barmpari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, “The Colorado thyroid disease prevalence study,” Archives of Internal Medicine, vol. 160, no. 4, pp. 526–534, 2000. View at Publisher · View at Google Scholar
  2. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. B. Panagiotakos, E. N. Georgousopoulou, C. Pitsavos et al., “Ten-year (2002-2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA study,” International Journal of Cardiology, vol. 1, no. 180, pp. 178–184, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Hollowell, N. W. Staehling, W. D. Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III),” Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar
  5. R. Kadiyala, R. Peter, and O. E. Okosieme, “Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies,” The International Journal of Clinical Practice, vol. 64, no. 8, pp. 1130–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Papazafiropoulou, A. Sotiropoulos, A. Kokoloki, M. Kardara, P. Stamataki, and S. Pappas, “Prevalence of thyroid dysfunction among Greek type 2 diabetic patients attending an outpatient clinic,” Journal of Clinical Medicine Research, vol. 2, no. 2, pp. 75–78, 2010. View at Publisher · View at Google Scholar
  7. L. H. Duntas, J. Orgiazzi, and G. Brabant, “The interface between thyroid and diabetes mellitus,” Clinical Endocrinology, vol. 75, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Gharib, R. M. Tuttle, J. Baskim, L. H. Fish, P. A. Singer, and M. T. McDermott, “Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 1, pp. 581–585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Völzke, U. Krohn, H. Wallaschofski, J. Lüdemann, U. John, and W. Kerner, “The spectrum of thyroid disorders in adult type 1 diabetes mellitus,” Diabetes Metabolism Research and Reviews, vol. 23, no. 3, pp. 227–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. P. Vanderpump, W. M. Tunbridge, J. M. French et al., “The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey,” Clinical Endocrinology, vol. 43, no. 1, pp. 55–68, 1995. View at Publisher · View at Google Scholar
  11. P. Perros, R. J. McCrimmon, G. Shaw, and B. M. Frier, “Frequency of thyroid dysfunction in diabetic patients: value of annual screening,” Diabetic Medicine, vol. 12, no. 7, pp. 622–627, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. A. R. Radaideh, M. K. Nusier, F. L. Amari et al., “Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan,” Saudi Medical Journal, vol. 25, no. 8, pp. 1046–1050, 2004. View at Google Scholar
  13. J. J. Díez, P. Sánchez, and P. Iglesias, “Prevalence of thyroid dysfunction in patients with type 2 diabetes,” Experimental and Clinical Endocrinology & Diabetes, vol. 119, no. 4, pp. 201–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. H. Akbar, M. M. Ahmed, and J. Al-Mughales, “Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics,” Acta Diabetologica, vol. 43, no. 1, pp. 14–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. B. Shun, K. C. Donaghue, H. Phelan, S. M. Twigg, and M. E. Craig, “Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis,” Diabetic Medicine, vol. 31, no. 2, pp. 126–135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Crunkhorn and M. E. Patti, “Links between thyroid hormone action, oxidative metabolism, and diabetes risk?” Thyroid, vol. 18, no. 2, pp. 227–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. F. F. Darendeliler, A. Kadioglu, B. Firdevs et al., “Thyroid ultrasound in IDDM,” Journal of Pediatric Endocrinology and Metabolism, vol. 7, pp. 733–737, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Hansen, F. N. Bennedbaek, L. K. Hansen, M. Hoier-Madsen, B. B. Jacobsen, and L. Hegedüs, “Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus,” European Journal of Endocrinology, vol. 140, no. 6, pp. 512–518, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Gómez, F. J. Maravall, A. Gumà, R. Abós, J. Soler, and M. Fernández-Castañer, “Thyroid volume as measured by ultrasonography in patients with type 1 diabetes mellitus without thyroid dysfunction,” Hormone and Metabolic Research, vol. 35, no. 8, pp. 486–491, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Junik, M. Kozinski, and K. Debska-Kozinska, “Thyroid ultrasound in diabetic patients without overt thyroid disease,” Acta Radiologica, vol. 47, no. 7, pp. 687–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. K. A. Iwen, E. Schroder, and G. Brabant, “Thyroid hormones and the metabolic syndrome,” European Thyroid Journal, vol. 2, no. 2, pp. 83–92, 2013. View at Publisher · View at Google Scholar
  22. W. P. Pimenta, G. M. Mazeto, C. F. Callegaro et al., “Thyroid disorders in diabetic patients,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 49, no. 2, pp. 234–240, 2005. View at Publisher · View at Google Scholar
  23. C. Anil, A. Akkurt, S. Ayturk, A. Kut, and A. Gursoy, “Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area,” Metabolism, vol. 62, no. 7, pp. 970–975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, and H. Niepomniszcze, “Introducing the thyroid gland as another victim of the insulin resistance syndrome,” Thyroid, vol. 18, no. 4, pp. 461–464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, and N. B. Tutuncu, “Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area,” European Journal of Endocrinology, vol. 161, no. 4, pp. 599–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer, “Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms,” Endocrine Reviews, vol. 29, no. 6, pp. 697–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Dora, W. E. Machado, J. Rheinheimer, D. Crispim, and A. L. Maia, “Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case–control study and meta-analysis,” European Journal of Endocrinology, vol. 163, no. 3, pp. 427–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. Celani, M. E. Bonati, and N. Stucci, “Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus,” Diabetes Research, vol. 27, no. 1, pp. 15–25, 1994. View at Google Scholar
  29. C. E. J. Udiong, A. E. Udoh, and M. E. Etukudoh, “Evaluation of thyroid function in diabetes mellitus in Calabar, Nigeria,” Indian Journal of Clinical Biochemistry, vol. 22, no. 2, pp. 74–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan, “The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies,” Endocrine Reviews, vol. 19, no. 6, pp. 673–716, 1998. View at Publisher · View at Google Scholar
  31. T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger, “Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models,” Endocrine Reviews, vol. 22, no. 5, pp. 631–656, 2001. View at Publisher · View at Google Scholar
  32. S. Fountoulakis, G. Philippou, and A. Tsatsoulis, “The role of iodine in the evolution of thyroid disease in Greece: from endemic goiter to thyroid autoimmunity,” Hormones, vol. 6, no. 1, pp. 25–35, 2007. View at Google Scholar
  33. L. Y. Aydin, Y. Aydin, F. H. Besir et al., “Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study,” Minerva Endocrinologica, vol. 36, no. 4, pp. 273–280, 2011. View at Google Scholar
  34. N. A. Georgopoulos, G. P. Sykiotis, A. Sgourou et al., “Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway,” European Journal of Endocrinology, vol. 149, no. 4, pp. 287–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mohan, D. J. Baylink, and J. L. Pettis, “Insulin-like growth factor (IGF)-binding proteins in serum--do they have additional roles besides modulating the endocrine IGF actions?” The Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 11, pp. 3817–3820, 1996. View at Publisher · View at Google Scholar
  36. H. Y. Yasar, Ö. Ertuğrul, B. Ertuğrul, D. Ertuğrul, and M. Şahin, “Insulin resistance in nodular thyroid disease,” Endocrine Research, vol. 36, no. 4, pp. 167–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Rochon, I. Tauveron, C. Dejax et al., “Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism,” Clinical Science, vol. 365, no. 3, pp. 7–15, 2003. View at Publisher · View at Google Scholar
  38. G. Dimitriadis, P. Mitrou, V. Lambadiari et al., “Insulin action in adipose tissue and muscle in hypothyroidism,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 12, pp. 4930–4937, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Maratou, D. J. Hadjidakis, A. Kollias et al., “Studies of insulin resistance in patients with clinical and subclinical hypothyroidism,” European Journal of Endocrinology, vol. 160, no. 5, pp. 785–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. N. Pearce, P. W. Wilson, Q. Yang, R. S. Vasan, and L. E. Braverman, “Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 3, pp. 888–894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. K. S. Lam, M. K. Chan, and R. T. Yeung, “High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction — effects of treatment,” QJM: An International Journal of Medicine, vol. 59, no. 229, pp. 513–521, 1986. View at Publisher · View at Google Scholar · View at Scopus
  42. R. P. Dullaart, K. Hoogenberg, J. E. Groener, L. D. Dikkeschei, D. W. Erkelens, and H. Doorenbos, “The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins,” European Journal of Clinical Investigation, vol. 20, no. 6, pp. 581–587, 1990. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Efstathiadou, S. Bitsis, H. J. Milionis et al., “Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?” European Journal of Endocrinology, vol. 145, no. 6, pp. 705–710, 2001. View at Publisher · View at Google Scholar
  44. American Diabetes Association, “Standards of medical care in diabetes 2016,” Diabetes Care, vol. 39, Supplement 1, 2016. View at Google Scholar
  45. L. Chaker, S. Ligthart, T. I. Korevaar et al., “Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study,” BMC Medicine, vol. 14, no. 1, p. 150, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Pappa and M. Alevizaki, “Metformin and thyroid: an update,” European Thyroid Journal, vol. 2, no. 1, pp. 22–28, 2013. View at Publisher · View at Google Scholar
  47. J. Rezzónico, M. Rezzónico, E. Pusiol, F. Pitoia, and H. Niepomniszcze, “Metformin treatment for small benign thyroid nodules in patients with insulin resistance,” Metabolic Syndrome and Related Disorders, vol. 9, no. 1, pp. 69–75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. J. Díez and P. Iglesias, “An analysis of the relative risk for goitre in euthyroid patients with type 2 diabetes,” Clinical Endocrinology, vol. 80, no. 3, pp. 356–361, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Davies and H. G. Welch, “Current thyroid cancer trends in the United States,” JAMA Otolaryngology-Head & Neck Surgery, vol. 140, no. 4, pp. 317–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Pellegriti, F. Frasca, C. Regalbuto, S. Squatrito, and R. Vigneri, “Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors,” Journal of Cancer Epidemiology, vol. 2013, Article ID 965212, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. G. D. Dimitriadis and S. A. Raptis, “Thyroid hormone excess and glucose intolerance,” Experimental and Clinical Endocrinology & Diabetes, vol. 109, Supplement 2, pp. S225–S239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Notara, D. B. Panagiotakos, M. Michalopoulou et al., “Diabetes mellitus, hypertension and hypercholesterolemia in relation to the 10-year ACS prognosis; the GREECS study,” Current Vascular Pharmacology, vol. 14, no. 3, pp. 295–301, 2016. View at Publisher · View at Google Scholar